Invention Grant
- Patent Title: Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor
-
Application No.: US15331612Application Date: 2016-10-21
-
Publication No.: US10525101B2Publication Date: 2020-01-07
- Inventor: Arthur A. Vandenbark , Gil Benedek , Roberto Meza-Romero
- Applicant: Oregon Health & Science University , The United States Government as represented by The Department of Veterans Affairs
- Applicant Address: US OR Portland US DC Washington
- Assignee: Oregon Health & Science University,The United States Government as Represented by the Department of Veterans Affairs
- Current Assignee: Oregon Health & Science University,The United States Government as Represented by the Department of Veterans Affairs
- Current Assignee Address: US OR Portland US DC Washington
- Agency: Klarquist Sparkman, LLP
- Main IPC: A61K38/10
- IPC: A61K38/10 ; A61K38/17 ; C07K14/74 ; A61K38/00
Abstract:
Recombinant polypeptides, pharmaceutical compositions comprising recombinant polypeptides, and methods of treating autoimmune and/or inflammatory diseases using the pharmaceutical compositions are disclosed. The polypeptides are based upon the trimerization and/or MIF binding domains of CD74.
Public/Granted literature
- US20170114117A1 COMPOUNDS THAT BIND MACROPHAGE MIGRATION INHIBITORY FACTOR Public/Granted day:2017-04-27
Information query
IPC分类:
